|Product Type||Primary Antibodies|
Programmed cell death ligand 1 (PD-L1) also known as cluster of differentiation (CD274) or B7 homolog 1 (B7-H1) is a type 1 transmembrane protein involved in the regulation of cellular and humoral immune responses. The interaction of PD-L1 with its receptor PD-1 provides both stimulatory and inhibitory signals in regulating T cell activation and tolerance during pregnancy, tissue allograft, autoimmune disease and malignant transformation. The binding of PD-L1 to PD-1 induces apoptosis or exhaustion in activated T cells, and blockade of this interaction has been shown to enhance the antitumor activity of T cells. PD-L1 is frequently over expressed in placenta, and many human tumours such as melanoma, diffuse large B-cell lymphoma, and carcinomas of the lung, bladder, breast, kidney and colon. Human CD274, PD-L1.
Immunogen: KLH-conjugated linear peptide from human PD-L1
Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide.**
Purification Method: Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide.**
Species Reactivity: Human
Working Concentration: (liquid conc.) 1:50-1:100
Pre-Treatment: Unmasking with Unmasking fluid E (Art. No. DE006) pH 9.0 or Unmasking fluid T (DE005) pH 8.0
Positive Control: Placenta, lung carcinoma (NSCLC)
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Nordic-MUbio accepts no liability for any inaccuracies or omissions in this information.
1. Ishida, Agata, Shibahara et al. (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. The EMBO journal, Vol. 11, Issue 11, pp. 3887-95 (PubMed). 2. Wang W, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2016) IFN-? up-regulates PD-L1 expression in human placenta mesenchymal stem cells and enhances cell ability to induce the differentiation of IL-10+ T cells from cord blood- and peripheral blood-derived T cells. PMID 26927379 3. Benjamin J. Chen, Bjoern Chapuy, Jing Ouyang, et al. (2013) PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies Clinical Cancer Research. CCR-13-0855
Database Name: UniProt
Accession number: Q9NZQ7 (PD1L1_HUMAN)
Species Accession: Human
Safety Datasheet(s) for this product:
/wp-content/uploads/SDS/Antibody SDS with Sodium Azide Noridic-MUbio.pdf